Published
Antiviral agents that are safe and effective against Covid-19 are lacking
worldwide. VV116 is a candidate oral antiviral agent with promising results in
preliminary studies.
New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3BT75ey
worldwide. VV116 is a candidate oral antiviral agent with promising results in
preliminary studies.
New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3BT75ey
- Category
- Health
Be the first to comment
-
01:01
U.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use
-
01:53
Oral COVID treatment
-
02:12
: S. Korea to receive COVID-19 oral treatment for 31,000 patients in January
-
04:10
COVID-19: Singapore to help develop oral antiviral treatment
-
03:01
The Medicine Box: Pfizer's Oral Anti-Viral Treatment For COVID-19
-
00:40
Pfizer's oral COVID-19 treatment shown to be effective against Omicron
-
02:07
S. Korea authorizes emergency use of Pfizer's oral COVID-19 treatment
-
01:49
U.S. authorizes Pfizer oral COVID-19 treatment, first for at-home use
-
05:33
New ORAL Treatment for COVID - What you need to know!
-
00:45
S. Korea to secure oral COVID-19 treatment for 404,000 patients
-
03:19
Jowar Khichdi Recipe | Healthy & Yummy | Gluten Free Weight Loss Millet Recipes | Culinary Aromas
-
08:07
৭ দিনে যৌন ক্ষমতা বাড়ানোর কুরআনী চিকিৎসা/ Treatment of metal corrosion disease in Bangla
-
00:12
Healthy Lifestyle
